FDA Inspection 1259644 — Alcami Carolinas Corporation

Alcami Carolinas Corporation — FEI 1049418

The FDA completed an inspection of Alcami Carolinas Corporation on January 31, 2025 in Wilmington, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 31, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Wilmington, NC (United States)

Citations

IDCFRDescription
361421 CFR 211.160(b)(4)Written calibration procedures